Log In
Print
BCIQ
Print
Print this Print this
 

MyoCell

  Manage Alerts
Collapse Summary General Information
Company Bioheart Inc.
DescriptionAutologous muscle stem cell therapy consisting of skeletal myoblast implantation by catheter delivery
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase III
Standard IndicationHeart failure
Indication DetailsTreat chronic heart failure (CHF) following myocardial infarction (MI); Treat severe heart damage in heart failure patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today